Hepatitis C Community
canabis
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank Blank

canabis

Journal of Hepatology
Volume 48, Issue 4, April 2008, Pages 657-665

Environmental factors as disease accelerators during chronic hepatitis C

Ariane Mallat, a, b, c, , Christophe Hezodea, b, c and Sophie Lotersztajna,
b, c

A Department of Hepatology and Gastroenterology, INSERM U841, Groupe
hospitalier Henri Mondor-Albert Chenevier, Créteil F-94000, France
B AP-HP, Groupe hospitalier Henri Mondor-Albert Chenevier, Service
d’Hépatologie et de Gastroentérologie, Créteil F-94000, France
C Université Paris 12, Faculté de Médecine, Créteil F-94000, France

Corresponding author.
Tel.: +33 (0) 1 49 81 23 67;
fax: +33 (0) 1 49 81 23 52.
ariane.***@****

Keywords: Alcohol; Tobacco; Hepatitis C virus; Chronic hepatitis C;
Cannabis; CB1 receptor; CB2 receptor; Cannabinoid

Progression of chronic hepatitis is highly variable among individuals, as
the result of several host, viral and environmental factors.
The latter have been extensively investigated in order to ameliorate
hepatitis C outcome, particularly in difficult-to-treat patients.
Over the last decade, several studies have shown that a combination of HCV
infection and high levels of alcohol abuse results in synergistic
acceleration of liver fibrogenesis.
In addition, recent data indicate that light alcohol intake may also
exacerbate fibrosis progression.
It has also been suggested that cigarette smoking may enhance activity grade
in patients with chronic hepatitis C, thereby increasing progression of
fibrosis.
This assumption mostly relies on epidemiological evidences in the absence of
pathogenic studies.
Finally, cannabis use is increasingly emerging as a novel co-morbidity in
patients with chronic hepatitis C.
Indeed, regular cannabis smoking is an independent predictor of both
fibrosis and steatosis severity in infected patients.
In addition, experimental studies have shown that cannabinoid CB1 receptors
enhance liver fibrogenesis and steatogenesis by distinct mechanisms,
therefore strongly supporting epidemiological findings.
Altogether, patients should be informed of the deleterious impact of
alcohol, tobacco and cannabis use and should be offered appropriate support
to achieve abstinence.

Related Discussions
190885_tn?1333029491
i don't know about the post but your profile cracked me up......i think a little pot isn't that bad...what about other pollution like from cars ..carpets...coal plants...bad water supply..and bombs....billy
Blank
Post a Comment
To
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis C Community Resources
RSS Expert Activity
242532_tn?1269553979
Blank
How to Silence Your Inner Critic an...
Apr 16 by Roger Gould, M.D.Blank
242532_tn?1269553979
Blank
Emotional Eaters: How to Silence Yo...
Mar 26 by Roger Gould, M.D.Blank
1344197_tn?1392822771
Blank
Vaginal vs. Laparoscopic Hysterecto...
Feb 19 by J. Kyle Mathews, MD, DVMBlank
Top Hepatitis Answerers
Avatar_m_tn
Blank
copyman
317787_tn?1373214989
Blank
Dee1956
DC
Avatar_m_tn
Blank
can-do-man
IN
Avatar_m_tn
Blank
willbb
446474_tn?1385271190
Blank
HectorSF
CA
1815939_tn?1377995399
Blank
pooh55811